Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Evommune signs $1.1bn licence deal with Hinova for EVO570 | PharmaVoice

Pharma Tech

Evommune signs $1.1bn licence deal with Hinova for EVO570

Nov 5, 2026, 10:36 AM

Read Full Article → Evommune signs $1.1bn licence deal with Hinova for EVO570

Evommune signs $1.1bn licence deal with Hinova for EVO570

Translate article text

Choose a language and wait for the translated text.

Evommune has secured exclusive rights outside Greater China to develop EVO570 from Hinova Pharmaceuticals in a deal worth up to $1.1bn.